Donor leukocyte infusions in relapsed Hodgkin's lymphoma following allogeneic stem cell transplantation: CD3+ cell dose, GVHD and disease response.

MLA

Anderlini, P., et al. “Donor Leukocyte Infusions in Relapsed Hodgkin’s Lymphoma Following Allogeneic Stem Cell Transplantation: CD3+ Cell Dose, GVHD and Disease Response.” Bone Marrow Transplantation, vol. 34, no. 6, Sept. 2004, pp. 511–14. EBSCOhost, https://doi.org/10.1038/sj.bmt.1704621.

APA

Anderlini, P., Acholonu, S. A., Okoroji, G.-J., Andersson, B. S., Couriel, D. R., De Lima, M. J., Donato, M. L., Khouri, I. F., Giralt, S. A., Ueno, N. T., & Champlin, R. E. (2004). Donor leukocyte infusions in relapsed Hodgkin’s lymphoma following allogeneic stem cell transplantation: CD3+ cell dose, GVHD and disease response. Bone Marrow Transplantation, 34(6), 511–514. https://doi.org/10.1038/sj.bmt.1704621

Chicago

Anderlini, P, S A Acholonu, G-J Okoroji, B S Andersson, D R Couriel, M J De Lima, M L Donato, et al. 2004. “Donor Leukocyte Infusions in Relapsed Hodgkin’s Lymphoma Following Allogeneic Stem Cell Transplantation: CD3+ Cell Dose, GVHD and Disease Response.” Bone Marrow Transplantation 34 (6): 511–14. doi:10.1038/sj.bmt.1704621.